Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Cash & Current Investments (2018 - 2025)

10x Genomics (TXG) has disclosed Cash & Current Investments for 8 consecutive years, with $523.4 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 33.05% to $523.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $523.4 million through Dec 2025, up 33.05% year-over-year, with the annual reading at $523.4 million for FY2025, 33.05% up from the prior year.
  • Cash & Current Investments hit $523.4 million in Q4 2025 for 10x Genomics, up from $482.1 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $640.1 million in Q2 2021 to a low of $222.4 million in Q4 2022.
  • Historically, Cash & Current Investments has averaged $433.3 million across 5 years, with a median of $408.2 million in 2023.
  • Biggest five-year swings in Cash & Current Investments: tumbled 62.14% in 2022 and later surged 74.79% in 2023.
  • Year by year, Cash & Current Investments stood at $587.4 million in 2021, then crashed by 62.14% to $222.4 million in 2022, then soared by 74.79% to $388.7 million in 2023, then rose by 1.21% to $393.4 million in 2024, then surged by 33.05% to $523.4 million in 2025.
  • Business Quant data shows Cash & Current Investments for TXG at $523.4 million in Q4 2025, $482.1 million in Q3 2025, and $447.3 million in Q2 2025.